Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1337 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 9/23/2026

FDA Greenlights Animal-Free Testing, Igniting 3D Cell Culture Market Boom

The 3D cell culture market is set for explosive growth, with a recent final rule from the U.S. Food and Drug Administration (FDA) on September 21, 2026, officially endorsing non-animal methods for drug safety testing. This landmark decision, building on the FDA Modernization Act 2.0, will accelerate the adoption of advanced 3D models like organoids and organ-on-chip systems, which offer more human-relevant insights than traditional animal studies. The market, valued between USD 1.2 billion and USD 3.96 billion in 2025, is now projected to hit up to USD 9.8 billion by 2030, driven by the urgent demand for better drug discovery tools and personalized medicine.

Editorial Team1 min
Technology 9/23/2026

One Shot, Three Foes: New CHO Cell Vaccine Targets COVID, Flu, and RSV

Scientists from the University of Montreal and National Research Council Canada have achieved a major breakthrough, developing a single, 'trivalent' vaccine that offers protection against SARS-CoV-2 (the virus causing COVID-19), influenza, and Respiratory Syncytial Virus (RSV) in one shot. This innovative vaccine uses Chinese Hamster Ovary (CHO) cells to produce virus-like particles (VLPs) that display key proteins from all three viruses. Early preclinical studies in mice showed highly promising results, with the vaccine inducing strong immune responses and completely protecting against lethal H1N1 influenza, paving the way for easier and broader protection against common respiratory illnesses.

Editorial Team1 min
One Shot, Three Foes: New CHO Cell Vaccine Targets COVID, Flu, and RSV
Technology 9/23/2026

AI Titans Address UN on Safety as Trump Rejects Global Rules, Pushing 'Super Intelligence'

Today, OpenAI's Sam Altman and Anthropic's Dario Amodei are addressing the UN Security Council, urging global cooperation on artificial intelligence safety and regulation. This high-stakes appeal directly follows former US President Donald Trump's declaration yesterday at the UN General Assembly, where he rejected any 'globalist scheme' for AI control, instead championing unfettered 'Super Intelligence' development.

Editorial Team1 min
AI Titans Address UN on Safety as Trump Rejects Global Rules, Pushing 'Super Intelligence'
Technology 9/23/2026

China's Stealth AI Threat: US Warns of 'Knowledge Distillation' Attacks

America's top security agencies — CISA, NSA, and FBI — issued a urgent warning on September 8, 2026, about a new and subtle threat from China: large-scale 'knowledge distillation' campaigns. Chinese AI companies are secretly copying the special abilities of advanced U.S. AI models, bypassing years of research and billions of dollars in development, likely with their government's support.

Editorial Team1 min
China's Stealth AI Threat: US Warns of 'Knowledge Distillation' Attacks
Technology 9/23/2026

ShinyHunters Claims Massive FBI Hack, Threatens Agent Data Leak in Retaliation

A notorious cybercrime group, ShinyHunters, is currently claiming it has successfully breached the Federal Bureau of Investigation's job application website, FBIjobs.gov, and stolen a massive 2-3 terabytes of highly sensitive data. This alleged haul reportedly includes personal information on 'almost all' FBI agents and job applicants, a claim that, if true, represents a significant national security incident. The group's motive appears to be direct retaliation for a May 2026 FBI FLASH report that detailed ShinyHunters' activities and advised victims against paying their demands, which the hackers dispute as 'false allegations'.

Editorial Team1 min
Technology 9/23/2026

Palo Alto Networks Unleashes AI Shield with Anthropic, OpenAI to Combat Cyber Threats

Palo Alto Networks just dropped a game-changer, launching its 'Unit 42 Continuous Frontier AI Defense' service, a subscription-based offering engineered to perpetually seek out and neutralize cyber vulnerabilities. This new shield combines cutting-edge AI models like Anthropic's Claude Mythos 5 and OpenAI's GPT-5.6-Cyber with Palo Alto's own threat intelligence, aiming to arm enterprises with machine-speed defense against rapidly evolving AI-powered attacks. The move signals a critical escalation in the cybersecurity arms race, as defenders scramble to match the automated prowess of modern threat actors.

Editorial Team1 min
Palo Alto Networks Unleashes AI Shield with Anthropic, OpenAI to Combat Cyber Threats
Technology 9/23/2026

Nvidia-Backed AI Drugmaker Iambic Files for IPO, Unveiling Cancer Drug Progress and Big Pharma Deals

Iambic Therapeutics, the AI-driven drug discovery firm backed by chip giant Nvidia and Qatar Investment Authority, has officially filed for its Initial Public Offering (IPO) on the Nasdaq. This move reveals fresh details on its clinical pipeline, including the progress of its lead cancer drug candidate, IAM1363, and growing partnerships with major pharmaceutical companies, signaling a maturing landscape for artificial intelligence in medicine. The San Diego-based company's S-1 filing outlines its intent to accelerate three early-stage cancer programs using the IPO proceeds.

Editorial Team1 min
Nvidia-Backed AI Drugmaker Iambic Files for IPO, Unveiling Cancer Drug Progress and Big Pharma Deals
Technology 9/23/2026

Apple's iOS 27.2 Beta Unveils 'AutoLock': A Smart Shield Against iPhone Theft

Apple's latest iOS 27.2 Beta 2 is buzzing with a super new anti-theft feature called 'AutoLock'. It's made to automatically lock iPhones the moment they're snatched. This isn't just a simple lock; it cleverly uses the iPhone's motion sensor, its connection to an Apple Watch, and changes in internet signals to instantly spot a possible theft and lock down the phone. This smart move could really mess up the illegal market for stolen phones.

Editorial Team1 min
Apple's iOS 27.2 Beta Unveils 'AutoLock': A Smart Shield Against iPhone Theft
Technology 9/23/2026

Celldex's Barzolvolimab Triumphs in Key Skin Disease Trials, Eyes 2027 FDA Nod

In a major win for patients battling severe chronic hives, Celldex Therapeutics has just announced that its investigational drug, barzolvolimab, hit all its targets in two large-scale Phase 3 trials for Chronic Spontaneous Urticaria (CSU). This breakthrough could pave the way for a new, highly effective treatment for millions struggling with the relentless itching and swelling of CSU, with Celldex planning to file for FDA approval in 2027.

Editorial Team1 min
Technology 9/22/2026

Apple's iPhone 'AutoLock' Feature: Your Device May Soon Fight Back Against Thieves

Apple is quietly developing a powerful new defense for its iPhones, an 'AutoLock' feature designed to automatically secure your device the instant it detects a snatch-and-grab theft. Details for this unannounced security measure, discovered in the code of iOS 27.2 beta 2, reveal how your iPhone could soon protect itself if physically taken while unlocked, significantly reducing a thief's window of opportunity.

Editorial Team1 min
Apple's iPhone 'AutoLock' Feature: Your Device May Soon Fight Back Against Thieves
Technology 9/22/2026

OpenAI's AI-Powered Math Claims Spark Debate, Prompt Independent Advisory Group

OpenAI has stirred the academic world by forming a new Mathematics Advisory Group, just days after claiming its internal AI model had solved over 100 tough math problems, including the famous Navier-Stokes Millennium Prize problem. This move comes amidst a heated debate on how to properly check and share proofs created by AI, especially since OpenAI hasn't yet released the full details or proofs for outside review.

Editorial Team1 min
Technology 9/22/2026

Deepfake Victim's Raw Court Testimony Ignites Global Call for AI Accountability

A young woman's powerful words have echoed through a courtroom, laying bare the 'painfully real' and lasting damage inflicted by sexually explicit deepfake images created and shared by 20-year-old William Yeates. This harrowing testimony, part of the ongoing legal fallout from Yeates' landmark conviction in Australia, spotlights the devastating personal cost of digital abuse and the urgent need for robust protections against AI-generated harm. The case is a grim reminder that while the images might be fake, the trauma is profoundly genuine.

Editorial Team1 min
Deepfake Victim's Raw Court Testimony Ignites Global Call for AI Accountability
Technology 9/22/2026

US Protein Labeling Market Surges as Next-Gen Proteomics and ADCs Drive Breakthroughs

The United States protein labeling market is experiencing a significant boom, projected to hit nearly $2 billion by 2031, fueled by groundbreaking advances in proteomics research and drug development. This robust growth, with a compound annual growth rate (CAGR) of 8.52% from 2026, is directly linked to the surging demand for precise protein analysis in personalized medicine and innovative therapies. New methods like AI-designed NovoTags are enhancing our ability to visualize and understand proteins, unlocking new possibilities in disease study.

Editorial Team1 min
Technology 9/22/2026

Novel Hypertension Drug Tonlamarsen Shows Lasting Blood Pressure Effects Post-Treatment

A groundbreaking study published in the Journal of American College of Cardiology and further elaborated at the European Society of Cardiology Congress 2026, reveals that the investigational drug Tonlamarsen leads to sustained reductions in plasma angiotensinogen and, crucially, persistent blood pressure improvements even after patients stop treatment. This marks a potential paradigm shift for millions suffering from uncontrolled hypertension, a condition where current daily medications often fall short in long-term adherence and efficacy. The KARDINAL trial demonstrated that while monthly Tonlamarsen doses significantly lowered plasma angiotensinogen more than a single dose, both regimens showed clinically meaningful reductions in office systolic blood pressure from baseline, with sustained effects after treatment cessation.

Editorial Team1 min
Novel Hypertension Drug Tonlamarsen Shows Lasting Blood Pressure Effects Post-Treatment
Technology 9/22/2026

Tripo AI's P2.0 Revolutionizes 3D Creation with Industry-First 'Quad Topology'

Tripo AI just dropped its latest AI model, Tripo P2.0, a game-changer for anyone working with 3D models. This new '3D-native foundation model' is making headlines because it's the first in the industry to create high-quality 3D assets using 'quad topology,' meaning digital objects are now truly 'production-ready' for things like video games and films right out of the AI generator. This marks a massive leap, finally bridging the gap between AI's creative power and the demanding needs of real-world production pipelines.

Editorial Team1 min
Technology 9/22/2026

Apple's M5 Ultra Shakes Up High-End GPU Arena, Nears RTX 5090 in AI Power

Apple's new M5 Ultra chip, powering the refreshed Mac Studio, is turning heads in the high-performance computing world, showing surprising muscle against Nvidia's top-tier GPUs. Recent benchmark results reveal the 80-core M5 Ultra GPU significantly outperforms the Nvidia GeForce RTX 5080 and impressively comes within 5% of the formidable RTX 5090 in critical professional applications like Blender. This powerful debut, part of Apple's latest chip lineup launched on August 25, 2026, signals a serious challenge to Nvidia's long-held dominance in high-end workstations and AI workloads, particularly with its massive unified memory architecture now hitting up to 512GB.

Editorial Team1 min
Technology 9/22/2026

IonQ and SDT Ignite South Korea's Quantum Future with New Superion 256 Deployment

US-based quantum computing leader IonQ has significantly expanded its footprint in the Asia-Pacific region, announcing a multi-year strategic partnership with South Korea's SDT Inc. This collaboration marks a major milestone, bringing the first IonQ Superion 256 quantum computer and a silicon-vacancy (SiV) quantum memory module to South Korea for local deployment. The move elevates their existing cloud software partnership to include physical hardware production and assembly, underscoring a growing global race in quantum technology.

Editorial Team1 min
IonQ and SDT Ignite South Korea's Quantum Future with New Superion 256 Deployment
Technology 9/22/2026

Louisiana Gears Up for SpaceX Spaceport: Education, Economy Face Seismic Shift

The Vermilion Parish School System in Louisiana is rapidly preparing for a massive transformation as SpaceX moves forward with its groundbreaking $100 billion 'Starbase Louisiana' project on Pecan Island. This colossal new launch facility, announced on August 25, 2026, is set to become the world's largest, promising thousands of daily rocket launches and a complete reshaping of the region's economy and educational landscape. Local school leaders are now scrambling to evaluate everything from staffing needs and classroom capacity to entirely new teaching programs, anticipating a significant population boom and new demands on their resources.

Editorial Team1 min
Louisiana Gears Up for SpaceX Spaceport: Education, Economy Face Seismic Shift
Technology 9/22/2026

AI Fuels 440% Surge in Untraceable Blockchain Malware, Rattling Global Cybersecurity

A new and alarming wave of cyberattacks is hitting hard, with hackers now burying malicious code and instructions directly onto public blockchains, making them almost impossible to remove. This sneaky tactic, supercharged by unrestricted AI models, has seen a staggering 440% surge in these types of attacks, creating a major headache for cybersecurity defenders worldwide.

Editorial Team1 min
AI Fuels 440% Surge in Untraceable Blockchain Malware, Rattling Global Cybersecurity
Technology 9/21/2026

Sydney Lab Unlocks Cancer's Toughest Secrets with Single-Cell Precision

The University of Sydney has just unveiled Australia's first dedicated ACRF Single Cell Cancer Proteomics Laboratory, a massive leap forward in understanding why some cancers stubbornly resist treatment. This cutting-edge facility, housed within the Sydney Mass Spectrometry at the Charles Perkins Centre, will let researchers dive deep into individual cancer and immune cells with unprecedented precision, targeting a significant hurdle in cancer therapy.

Editorial Team1 min
Sydney Lab Unlocks Cancer's Toughest Secrets with Single-Cell Precision
‹ Prev1…910111213…67Next ›

Page 11 of 67 · 1337 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies